Screening for Protein Markers from Serum of Patients with Pancreatic Carcinoma by Protein Finger Printing Technique

dinghui GUO,Shuncai ZHANG,Wenjing WANG,Ping LIAO,Dayong JIN,Wenhui LOU,Jiong WU
DOI: https://doi.org/10.3969/j.issn.1000-8179.2008.17.010
2008-01-01
Clinical Oncology and Cancer Research
Abstract:Objective: To screen for protein markers from serum of patients with pancreatic carcinoma by SELDI-TOF-MS. Methods: A case-control study of 18 serum samples from patients with pancteatic carcinoma and 18 serum samples from healthy control was carried out with strong anionic exchange proteinchip. Results: Analyzed by SELDI-TOF-MS with SAX, eight protein biomarkers were identified including three up-regulated protein biomarkers with relative molecular weights of 4136.60, 4465.92 and 4359.53Da, respectively and five down-regulated ones with relative molecular weights of 5856.8, 7564.52, 5116.1, 2042.78 and 2016.44 Da, respectively in the serum of patients with pancreatic carcinoma compared with the healthy controls. There was a statistical difference in one protein biomarker with weight of 4136.60Da between 11 cases of pancreatic duct adenocarcinoma and 7 cases of other kinds of carcinoma. ROC curve analysis revealed that these six identified protein biomarkers had a sensitivity of 83%-94% and a specificity of 56%-67% for the diagnosis of pancreatic carcinoma. Conclusion: Some potential protein biomarkers with good sensitivity and specificity in the serum of patients with pancreatic carcinoma can be helpful for the diagnosis of pancreatic carcinoma.
What problem does this paper attempt to address?